NEW YORK – A study evaluating the efficacy of molecular tumor board recommendations at the University Medical Center Groningen found that lung cancer patients' treating doctors were willing to take up the expert body's targeted therapy recommendations, and when they did, these treatments shrunk tumors in two-thirds of patients.
The results of the retrospective analysis were published last week in JCO Precision Oncology.